heart medications

5. 1-2 of these should be the maximum amount of time spent on pushing in adenosine
6. this describes how often you will assess perfusion while on epinephrine
8. Agents that improve myocardial contractility and enhance stroke volume
9. is administered to keep the PDA open for ductal dependent congenital heart defects
10. this is improved when dopamine is being administered
14. describes the proper method to administer dopamine
15. this causes vasodilation, improves contractility of the heart, and decreases PVR and SVR
16. describes the systemic vascular resistance while on dopamine
19. this demand is increased by the myocardium while on epinephrine
21. describes what happens to the tissue around a PIV that is infiltrated while administering dobutamine
22. agents that increase systemic vascular resistance thus increasing blood pressure

1. describes the rate at which to administer calcium so as not to cause hypotension
2. is the side effect of most concern while caring for a patient on prostaglandin E
3. describes what happens to the peripheral vasculature while on epinephrine
4. has more of an effect on cardiac output than dopamine with less effect on blood pressure
7. is a cardiac stimulant that increases heart rate and the strength of cardiac contractions
11. is an inotrope that is the first line drug for low blood pressure in the NICU
12. a sign of this drug is reaching toxic levels is bradycardia
13. describes how frequently you would record vital signs while on inotropes
17. is the drug used to treat SVT
18. describes the low dose of dopamine at 1-3 mcg/kg/min
20. is the device used to help administer adenosine appropriately